Strain Information | |
---|---|
Image | |
BRC No. | RBRC05928 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6.Cg-Map3k5<tm1Hijo> Map3k6<tm1Hijo> Map3k15<tm1Hijo> |
Former Common name | ASK1/2/3-TKO |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Hidenori Ichijo, Graduate School of Pharmaceutical Sciences, The University of Tokyo. The triple mutant mice were generated by crossing with Map3k5 KO mice, Map3k6 KO mice and Map3k15 KO mice. C57BL/6J background. |
Strain description | Map3k5 (ASK1) and Map3k15 (ASK3) genes triple knockout mice. The coding region of Exon 1 of Map3k5 gene was replaced with a GFP/PGK-neo cassette (GFP expression was not observed). The exons 1 to 5 of Map3k6 were replaced with a NLS-lacZ cassette and a pgk-neo cassette. A part of exon 1 of Map3k15 was replaced with a neo cassette. Triple homozygous mutant mice are viable and fertile. |
Colony maintenance | Map3k5: Homozygote x Homozygote; Map3k6: Homozygote x Homozygote; Map3k15: Homozygote (female) x Hemizygote (male) [or Crossing to C57BL/6JJcl] |
References | ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H EMBO J., 28, 843-853 (2009). 11266364Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. Takeda K, Shimozono R, Noguchi T, Umeda T, Morimoto Y, Naguro I, Tobiume K, Saitoh M, Matsuzawa A, Ichijo H J. Biol. Chem., 282, 7522-7531 (2007). 17210579ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney. Naguro I, Umeda T, Kobayashi Y, Maruyama J, Hattori K, Shimizu Y, Kataoka K, Kim-Mitsuyama S, Uchida S, Vandewalle A, Noguchi T, Nishitoh H, Matsuzawa A, Takeda K, Ichijo H Nat Commun. (2012). 23250415ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H EMBO rep., 2, 222-228 (2001). 11266364 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
GFP | Green Fluorescent Protein (Aequorea victoria) | 10 | |||||
GH | Growth hormone polyA (Bovine) | 10 | GH | ||||
Map3k5 | mitogen-activated protein kinase kinase kinase 5 | 10 | Map3k5 | targeted mutation 1, Hidenori Ichijo | |||
neo | neomycin resistance gene (E. coli) | 10 | mouse phosphoglycerate kinase promoter (PGK promoter) | ||||
GH | Growth hormone polyA (Bovine) | 4 | GH | ||||
Map3k6 | mitogen-activated protein kinase kinase kinase 6 | 4 | Map3k6 | targeted mutation 1, Hidenori Ichijo | |||
lacZ | beta-galactosidase (E. coli) | 4 | |||||
neo | neomycin resistance gene (E. coli) | 4 | mouse phosphoglycerate kinase promoter (PGK promoter) | ||||
nls | SV40 large T antigen nuclear localization signal (NLS) | 4 | nls | ||||
Map3k15 | mitogen-activated protein kinase kinase kinase 15 | X | Map3k15 | targeted mutation 1, Hidenori Ichijo | |||
loxP | phage P1 loxP | X | loxP | ||||
loxP | phage P1 loxP | X | loxP | ||||
neo | neomycin resistance gene (E. coli) | X |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 10 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Mouse Phosphoglycerate kinase promoter (PGK promoter), E. coli Neomycin resistance gene, mouse Pgk polyA, Jellyfish (Aequorea victoria) GFP cDNA, Bovine growth hormone PolyA signal, Mouse Map3k5 genomic DNA, SV40 nuclear localization signal sequence, E. coli beta-galactosidase, Mouse Map3k6 genomic DNA, P1 Phage loxP sites, Klebsiella pneumoniae Neomycin resistance gene, Mouse Map3k15 genomic DNA |
Research application | Apoptosis Research Cre/loxP system Fluorescent Proteins/lacZ System Immunology and Inflammation Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Hidenori Ichijo (The University of Tokyo) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |